RemSleep Holdings Inc. Issues Letter to Shareholders
Tampa, FL, Jan. 06, 2023 (GLOBE NEWSWIRE) — RemSleep Holdings Inc. (OTCQB:RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today provides a corporate update and letter to shareholders from CEO Tom Wood.
Related news for (RMSL)
- REMSleep Holdings Patent Status
- REMSleep Holdings Shareholder Update
- Remsleep Holdings Inc.’s DeltaWave Mask Moves to Substantive Review of FDA 510k Process
- RemSleep Holdings Inc. Announces Submission of DeltaWave Mask for FDA 510K Review
- RemSleep Holdings Inc. Provides an Update on Funding and DeltaWave